Latest Operational Cash Flow News

One Click Group reported a robust September quarter with $1.6 million positive operating cash flow and 27% revenue growth, fueled by strong user acquisition and a new cash advance product rollout.

Clean TeQ Water Limited reports strong Q1 FY26 progress, securing major contracts and boosting cash reserves amid advancing proprietary water treatment technologies.

Greatland Resources has reported a standout September quarter with record gold recovery at its Telfer mine and strong cash flow that has already surpassed its acquisition cost. The company is advancing key growth projects at Telfer and Havieron, setting the stage for sustained production.

Greatland Resources delivered a robust start to FY26, reporting strong gold and copper production alongside significant cash flow and promising exploration results at Telfer.

AML3D Limited reported steady quarterly receipts alongside a landmark US Navy Letter of Intent and significant orders, underpinning a major growth phase in the US and Europe.

Ramelius Resources delivered a robust September quarter with strong gold production and cash flow, completing its transformative acquisition of Spartan Resources and advancing key exploration and feasibility studies.

Minbos Resources advances its Cabinda phosphate fertilizer project with key funding restructures, minority shareholder buyouts, and the start of early mining operations. Strategic partnerships and construction milestones position the company for growth despite funding delays.

Bega Cheese delivered a robust FY2025 performance with a 23% rise in normalised EBITDA and a 74% jump in profit after tax, underpinned by strategic brand growth and operational efficiencies. The company raised its FY2026 EBITDA guidance and outlined ambitious plans for international expansion and product innovation.

OZZ Resources advances exploration with fresh gold anomalies at Maguires Reward and pursues a joint venture to unlock project potential amid ongoing ASX suspension.

Newmont Corporation reported a strong third quarter in 2025, driven by higher gold prices and successful divestitures of non-core assets, enhancing liquidity and reducing debt. The company’s operational shifts and cost management reflect a strategic pivot in a volatile market.

thl reported a tough FY25 with a 45% drop in underlying profit and a statutory loss, but is charting a strategic turnaround while rejecting a $2.30 per share acquisition offer.

Lumos Diagnostics reported steady quarterly revenue with a 300% surge in product sales, driven by its flagship FebriDx® test. The company inked a landmark US$317 million exclusive U.S. distribution agreement and awaits FDA feedback on its CLIA waiver application.